药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Butobarbital
Dichlorvos
The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Dichlorvos.
Butobarbital
Coumaphos
The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Coumaphos.
Butobarbital
Capsaicin
The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Capsaicin.
Butobarbital
Glycine betaine
The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Glycine betaine.
Butobarbital
Aprotinin
The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Aprotinin.
Butobarbital
Regramostim
The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Regramostim.
Butobarbital
Phenserine
The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Phenserine.
Butobarbital
Huperzine A
The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Huperzine A.
Butobarbital
Thiotepa
The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Thiotepa.
Butobarbital
1,10-Phenanthroline
The therapeutic efficacy of Umeclidinium can be decreased when used in combination with 1,10-Phenanthroline.
Butobarbital
Bambuterol
The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Bambuterol.
Butobarbital
Neostigmine
The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Neostigmine.
Butobarbital
Ginkgo biloba
The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Ginkgo biloba.
Butobarbital
Cannabinol
The risk or severity of Tachycardia and drowsiness can be increased when Umeclidinium is combined with Cannabinol.
Butobarbital
Palmidrol
The risk or severity of Tachycardia and drowsiness can be increased when Umeclidinium is combined with Palmidrol.
Butobarbital
Nabiximols
The risk or severity of Tachycardia and drowsiness can be increased when Umeclidinium is combined with Nabiximols.
Butobarbital
WIN 55212-2
The risk or severity of Tachycardia and drowsiness can be increased when Umeclidinium is combined with WIN 55212-2.
Butobarbital
Surinabant
The risk or severity of Tachycardia and drowsiness can be increased when Umeclidinium is combined with Surinabant.
Butobarbital
Ibipinabant
The risk or severity of Tachycardia and drowsiness can be increased when Umeclidinium is combined with Ibipinabant.
Butobarbital
Ajulemic acid
The risk or severity of Tachycardia and drowsiness can be increased when Umeclidinium is combined with Ajulemic acid.